Reply

Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)248-249
Number of pages2
JournalJournal of the American College of Cardiology
Volume69
Issue number2
DOIs
Publication statusPublished - Jan 17 2017

Keywords

  • Letter

Cite this

@article{f3e84273a2d44d6ea104d131e2e6cad7,
title = "Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?",
keywords = "Letter",
author = "Andrea Mazzanti and Riccardo Maragna and Carlo Napolitano and Priori, {Silvia G}",
year = "2017",
month = "1",
day = "17",
doi = "10.1016/j.jacc.2016.09.981",
language = "English",
volume = "69",
pages = "248--249",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Reply

T2 - Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3?

AU - Mazzanti, Andrea

AU - Maragna, Riccardo

AU - Napolitano, Carlo

AU - Priori, Silvia G

PY - 2017/1/17

Y1 - 2017/1/17

KW - Letter

U2 - 10.1016/j.jacc.2016.09.981

DO - 10.1016/j.jacc.2016.09.981

M3 - Article

VL - 69

SP - 248

EP - 249

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 2

ER -